Reply: the inclusion of methylphenidate in the WHO list of essential medicines is endorsed by millions of people with ADHD.

Cortese, Samuele; Coghill, David; Fegert, Joerg M; Mattingly, Gregory W; Rohde, Luis A; Wong, Ian C K; Faraone, Stephen V

Cortese, Samuele; Coghill, David; Fegert, Joerg M; Mattingly, Gregory W; Rohde, Luis A; Wong, Ian C K; Faraone, Stephen V.

Afiliação

Cortese S; Center for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Highfield Campus, Building 44, Southampton, SO17 1BJ, UK. samuele.cortese@soton.ac.uk.
Coghill D; Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK. samuele.cortese@soton.ac.uk.
Fegert JM; Solent NHS Trust, Southampton, UK. samuele.cortese@soton.ac.uk.
Mattingly GW; Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York, NY, USA. samuele.cortese@soton.ac.uk.
Rohde LA; Departments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, Australia.
Wong ICK; Murdoch Children's research Institute, Melbourne, Australia.
Faraone SV; Klinik für Kinder- und Jugendpsychiatrie / Psychotherapie, Universitatsklinikum Ulm, Ulm, Germany.

Eur Child Adolesc Psychiatry ; 2024 Aug 28.

Article em En | MEDLINE | ID: mdl-39196420

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Child Adolesc Psychiatry Assunto da revista: PEDIATRIA / PSIQUIATRIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google